A Preview Of Lantern Pharma's Earnings
Portfolio Pulse from Benzinga Insights
Lantern Pharma (NASDAQ:LTRN) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.45. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $2.95, down 30.89% over the last 52-week period.
November 07, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Lantern Pharma's upcoming earnings report could impact its stock price. The company has a history of mixed earnings performance, which has led to changes in its share price. The stock is currently down 30.89% over the last 52-week period.
The upcoming earnings report is a significant event for any company and can lead to changes in stock price. In the case of Lantern Pharma, past earnings reports have resulted in both increases and decreases in share price. Given the current downward trend of the stock, investors will be closely watching this report.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100